Shuming Chen, Tracee L McMiller, Abha Soni, Farah Succaria, John-William Sidhom, Laura C Cappelli, Livia A Casciola-Rosen, Isaac R Morales, Preethi Sankaran, Alan E Berger, Julie Stein Deutsch, Qingfeng C Zhu, Robert A Anders, Jody E Hooper, Drew M Pardoll, Evan J Lipson, Janis M Taube, Suzanne L Topalian
BACKGROUND: Tumor regression following immune checkpoint blockade (ICB) is often associated with immune-related adverse events (irAEs), marked by inflammation in non-cancerous tissues. This study was undertaken to investigate the functional relationship between anti-tumor and anti-self immunity, to facilitate irAE management while promoting anti-tumor immunity. METHODS: Multiple biopsies from tumor and inflamed tissues were collected from a patient with melanoma experiencing both tumor regression and irAEs on ICB, who underwent rapid autopsy...
March 5, 2024: Journal of Translational Medicine